Innovaderma logo

MLIDP - Innovaderma Share Price

€0.7 0.0  0.0%

Last Trade - 05/09/16

Sector
Consumer Defensives
Size
Micro Cap
Market Cap £9.71m
Enterprise Value £9.62m
Revenue £14.1m
Position in Universe th / 852
Bullish
Bearish
Unlock MLIDP Revenue
Momentum
Relative Strength (%)
1m -31.5%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.56 4.30 8.86 10.7 12.9 14.7 16.4 +119.3%
+250.5 -50.7 +134.9 +35.6 +17.9
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 31 December 2019, Innovaderma PLC revenues increased 33% to £5.1M. Net loss decreased 13% to £270K. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Administrave expenses decrease of 3% to £699K (expense). Basic Earnings per Share excluding Extraordinary Items remained flat at -£0.02.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

MLIDP Revenue Unlock MLIDP Revenue

Net Income

MLIDP Net Income Unlock MLIDP Revenue

Normalised EPS

MLIDP Normalised EPS Unlock MLIDP Revenue

PE Ratio Range

MLIDP PE Ratio Range Unlock MLIDP Revenue

Dividend Yield Range

MLIDP Dividend Yield Range Unlock MLIDP Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
MLIDP EPS Forecasts Unlock MLIDP Revenue
Profile Summary

InnovaDerma PLC is a holding company. The Company develops a range of male and female at-home and clinically proven treatments for hair loss, hair care, self-tanning and skin rejuvenation. It operates through hair and beauty division. Its products include Leimov Personal Hair Laser Starter Kit, Leimov Hair Treatment Pack, Leimov Bio Cleansing Shampoo, Leimov Thickening Conditioner, Leimov Scalp Therapy Day Treatment, Leimov Scalp Serum Night Treatment, Leimov Deep Cleansing Scalp and Body, Leimov Hair Treatment Pack for Her, Leimov Personal Hair Laser Starter Kit for Her, Leimov Vitality Shampoo, Leimov Follicle Boost Therapy, Leimov BioPlex Scalp Serum, Leimov Scalp and Body Exfoliating Spa, Leimo Instant Hair Introductory Pack, Leimo Instant Hair Regular Pack, Leimo Instant Hair Building Fiber, Skinny Tan-Ab Shader, Skinny Tan-Dermabrasion Pre-tan Primer, and Tan and Glow. It operates in the United Kingdom, the United States, Australia, New Zealand, the Philippines and South Africa.

Directors
Last Annual June 30th, 2019
Last Interim December 31st, 2019
Incorporated September 19, 2014
Public Since May 6, 2015
No. of Shareholders: n/a
No. of Employees: 41
Sector Consumer Defensives
Industry Personal & Household Products & Services
Index
Exchange Euronext - Paris
Shares in Issue 14,496,633
Free Float (0.0%)
Eligible for
ISAs
SIPPs
MLIDP Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for MLIDP
Upcoming Events for MLIDP
Frequently Asked Questions for Innovaderma
What is the Innovaderma share price?

As of 05/09/16, shares in Innovaderma are trading at €0.7, giving the company a market capitalisation of £9.71m. This share price information is delayed by 15 minutes.

How has the Innovaderma share price performed this year?

Shares in Innovaderma are currently trading at €0.7 and the price has moved by -81.82% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Innovaderma price has moved by -81.09% over the past year.

What are the analyst and broker recommendations for Innovaderma?

There are no analysts currently covering Innovaderma.

When will Innovaderma next release its financial results?

Innovaderma is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2020-12-31
What is the Innovaderma dividend yield?

Innovaderma does not currently pay a dividend.

Does Innovaderma pay a dividend?

Innovaderma does not currently pay a dividend.

When does Innovaderma next pay dividends?

Innovaderma does not currently pay a dividend.

How do I buy Innovaderma shares?

To buy shares in Innovaderma you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Innovaderma?

Shares in Innovaderma are currently trading at €0.7, giving the company a market capitalisation of £9.71m.

Where are Innovaderma shares listed? Where are Innovaderma shares listed?

Here are the trading details for Innovaderma:

Country of listing: France
Exchange: PAR
Ticker Symbol: MLIDP
What kind of share is Innovaderma?

We were not able to load our ranking data for Innovaderma

Is there a Innovaderma share price forecast 2020?

We were not able to load any forecast data for Innovaderma.

How can I tell whether the Innovaderma share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Innovaderma. Over the past six months, the relative strength of its shares against the market has been -61.05%. At the current price of €0.7, shares in Innovaderma are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Innovaderma PE Ratio?

We were not able to find PE ratio data for Innovaderma.

Who are the key directors of Innovaderma?

We were unable to find the directors for Innovaderma.

Who are the major shareholders of Innovaderma?

Here are the top five shareholders of Innovaderma based on the size of their shareholding:

Ward (Mark Michael) Individual Investor
Percentage owned: 10.9% (1.58m shares)
Edale Capital LLP Hedge Fund
Percentage owned: 9.11% (1.32m shares)
Aracil (Ariadna Greñan) Individual Investor
Percentage owned: 4.04% (586k shares)
Bayer (Joseph) Individual Investor
Percentage owned: 1.44% (209k shares)
Andrews (Ross Martin) Individual Investor
Percentage owned: 0.65% (94.9k shares)
Similar to MLIDP
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.